BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 21670739)

  • 21. Regulation of class II MHC expression in APCs: roles of types I, III, and IV class II transactivator.
    Pai RK; Askew D; Boom WH; Harding CV
    J Immunol; 2002 Aug; 169(3):1326-33. PubMed ID: 12133955
    [TBL] [Abstract][Full Text] [Related]  

  • 22. TLR2-dependent inhibition of macrophage responses to IFN-gamma is mediated by distinct, gene-specific mechanisms.
    Benson SA; Ernst JD
    PLoS One; 2009 Jul; 4(7):e6329. PubMed ID: 19629181
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Autoimmunity and inflammation are independent of class II transactivator type PIV-dependent class II major histocompatibility complex expression in peripheral tissues during collagen-induced arthritis.
    Waldburger JM; Palmer G; Seemayer C; Lamacchia C; Finckh A; Christofilopoulos P; Baeten D; Reith W; Gabay C
    Arthritis Rheum; 2011 Nov; 63(11):3354-63. PubMed ID: 21739421
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Histone deacetylation, but not hypermethylation, modifies class II transactivator and MHC class II gene expression in squamous cell carcinomas.
    Kanaseki T; Ikeda H; Takamura Y; Toyota M; Hirohashi Y; Tokino T; Himi T; Sato N
    J Immunol; 2003 May; 170(10):4980-5. PubMed ID: 12734341
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Nitric oxide inhibits INFgamma-induced increases in CIITA mRNA abundance and activation of CIITA dependent genes--class II MHC, Ii and H-2M. Class II TransActivator.
    Kielar ML; Sicher SC; Penfield JG; Jeyarajah DR; Lu CY
    Inflammation; 2000 Oct; 24(5):431-45. PubMed ID: 10921507
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A CIITA-independent pathway that promotes expression of endogenous rather than exogenous peptides in immune-privileged sites.
    Arancibia-Cárcamo CV; Osawa H; Arnett HA; Háskova Z; George AJ; Ono SJ; Ting JP; Streilein JW
    Eur J Immunol; 2004 Feb; 34(2):471-80. PubMed ID: 14768052
    [TBL] [Abstract][Full Text] [Related]  

  • 27. CCAAT/enhancer-binding protein beta and delta binding to CIITA promoters is associated with the inhibition of CIITA expression in response to Mycobacterium tuberculosis 19-kDa lipoprotein.
    Pennini ME; Liu Y; Yang J; Croniger CM; Boom WH; Harding CV
    J Immunol; 2007 Nov; 179(10):6910-8. PubMed ID: 17982082
    [TBL] [Abstract][Full Text] [Related]  

  • 28. HLA class II expression in uninducible hepatocarcinoma cells after transfection of AIR-1 gene product CIITA: acquisition of antigen processing and presentation capacity.
    Sartoris S; Valle MT; Barbaro AL; Tosi G; Cestari T; D'Agostino A; Megiovanni AM; Manca F; Accolla RS
    J Immunol; 1998 Jul; 161(2):814-20. PubMed ID: 9670958
    [TBL] [Abstract][Full Text] [Related]  

  • 29. TNF-alpha suppresses IFN-gamma-induced MHC class II expression in HT1080 cells by destabilizing class II trans-activator mRNA.
    Han Y; Zhou ZH; Ransohoff RM
    J Immunol; 1999 Aug; 163(3):1435-40. PubMed ID: 10415044
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Major histocompatibility complex class II transactivator (CIITA) hammer- head ribozyme transfer inhibits major histocompatibility complex class II (MHC-II) expression in Jukart cells].
    Guo R; Zou P; Song YP; Ma J; Lu HZ; Cao YL; Tong YJ
    Zhonghua Er Ke Za Zhi; 2003 Dec; 41(12):925-8. PubMed ID: 14723817
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Class II transactivator-mediated regulation of major histocompatibility complex class II antigen expression is important for hematopoietic progenitor cell suppression by chemokines and iron-binding proteins.
    Broxmeyer HE; Cooper S; Hangoc G; Chang CH
    Exp Hematol; 2006 Aug; 34(8):1078-84. PubMed ID: 16863914
    [TBL] [Abstract][Full Text] [Related]  

  • 32. ERK and p38 MAPK signaling pathways negatively regulate CIITA gene expression in dendritic cells and macrophages.
    Yao Y; Xu Q; Kwon MJ; Matta R; Liu Y; Hong SC; Chang CH
    J Immunol; 2006 Jul; 177(1):70-6. PubMed ID: 16785500
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Positive regulatory domain I-binding factor 1 mediates repression of the MHC class II transactivator (CIITA) type IV promoter.
    Chen H; Gilbert CA; Hudson JA; Bolick SC; Wright KL; Piskurich JF
    Mol Immunol; 2007 Feb; 44(6):1461-70. PubMed ID: 16765445
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A role for EZH2 in silencing of IFN-gamma inducible MHC2TA transcription in uveal melanoma.
    Holling TM; Bergevoet MW; Wilson L; Van Eggermond MC; Schooten E; Steenbergen RD; Snijders PJ; Jager MJ; Van den Elsen PJ
    J Immunol; 2007 Oct; 179(8):5317-25. PubMed ID: 17911618
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Polycomb recruitment at the Class II transactivator gene.
    Boyd NH; Morgan JE; Greer SF
    Mol Immunol; 2015 Oct; 67(2 Pt B):482-91. PubMed ID: 26283540
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Absence of MHC class II antigen expression in trophoblast cells results from a lack of class II transactivator (CIITA) gene expression.
    Murphy SP; Tomasi TB
    Mol Reprod Dev; 1998 Sep; 51(1):1-12. PubMed ID: 9712312
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The arginine methyltransferase PRMT5 regulates CIITA-dependent MHC II transcription.
    Fan Z; Kong X; Xia J; Wu X; Li H; Xu H; Fang M; Xu Y
    Biochim Biophys Acta; 2016 May; 1859(5):687-96. PubMed ID: 26972221
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Reduced IL-4-, lipopolysaccharide-, and IFN-gamma-induced MHC class II expression in mice lacking class II transactivator due to targeted deletion of the GTP-binding domain.
    Itoh-Lindstrom Y; Piskurich JF; Felix NJ; Wang Y; Brickey WJ; Platt JL; Koller BH; Ting JP
    J Immunol; 1999 Sep; 163(5):2425-31. PubMed ID: 10452977
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Varying functions of specific major histocompatibility class II transactivator promoter III and IV elements in melanoma cell lines.
    Goodwin BL; Xi H; Tejiram R; Eason DD; Ghosh N; Wright KL; Nagarajan U; Boss JM; Blanck G
    Cell Growth Differ; 2001 Jun; 12(6):327-35. PubMed ID: 11432807
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Differential Early Secreted Antigen Target (ESAT) 6 kDa-induced IFN-γ and SOCS1 expression distinguishes latent and active tuberculosis.
    Masood KI; Hussain R; Rao N; Rottenberg ME; Salahuddin N; Irfan M; Hasan Z
    J Infect Dev Ctries; 2014 Jan; 8(1):59-66. PubMed ID: 24423713
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.